IL13 and inflammatory bowel disease: In the future, we believe that it would be possible to more accurately recapitulate the pathophysiology of UC by treating hiPSC-COs with cytokines and bacterial component or co-culturing hiPSC-COs with immune cells that produce a variety of IBD-related inflammatory cytokines, including IL-13.